These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30415894)

  • 1. Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A
    Barresi E; Giacomelli C; Daniele S; Tonazzini I; Robello M; Salerno S; Piano I; Cosimelli B; Greco G; Da Settimo F; Martini C; Trincavelli ML; Taliani S
    Bioorg Med Chem; 2018 Dec; 26(22):5885-5895. PubMed ID: 30415894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward PET imaging of A2B adenosine receptors: a carbon-11 labeled triazinobenzimidazole tracer: Synthesis and imaging of a new A2B PET tracer.
    Petroni D; Giacomelli C; Taliani S; Barresi E; Robello M; Daniele S; Bartoli A; Burchielli S; Pardini S; Salvadori PA; Da Settimo F; Martini C; Trincavelli ML; Menichetti L
    Nucl Med Biol; 2016 May; 43(5):309-17. PubMed ID: 27150034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one: a novel template for the design of highly selective A₂B adenosine receptor antagonists.
    Taliani S; Pugliesi I; Barresi E; Simorini F; Salerno S; La Motta C; Marini AM; Cosimelli B; Cosconati S; Di Maro S; Marinelli L; Daniele S; Trincavelli ML; Greco G; Novellino E; Martini C; Da Settimo F
    J Med Chem; 2012 Feb; 55(4):1490-9. PubMed ID: 22257095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
    Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
    Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulators of human A2B adenosine receptor.
    Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
    Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.
    Scatena A; Fornai F; Trincavelli ML; Taliani S; Daniele S; Pugliesi I; Cosconati S; Martini C; Da Settimo F
    ACS Chem Neurosci; 2011 Sep; 2(9):526-35. PubMed ID: 22860174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-amino-6-alkyloxy-2-alkylthiopyrimidine derivatives as novel non-nucleoside agonists for the adenosine A
    Cosimelli B; Greco G; Laneri S; Novellino E; Sacchi A; Trincavelli ML; Giacomelli C; Taliani S; Da Settimo F; Martini C
    Chem Biol Drug Des; 2016 Nov; 88(5):724-729. PubMed ID: 27282729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted 4-phenylthiazoles: Development of potent and selective A
    Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE
    Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chalcone-based derivatives as new scaffolds for hA3 adenosine receptor antagonists.
    Vazquez-Rodriguez S; Matos MJ; Santana L; Uriarte E; Borges F; Kachler S; Klotz KN
    J Pharm Pharmacol; 2013 May; 65(5):697-703. PubMed ID: 23600387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives.
    Chandrasekaran B; Samarneh S; Jaber AMY; Kassab G; Agrawal N
    Curr Pharm Des; 2019; 25(25):2741-2771. PubMed ID: 31333084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
    Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
    Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility.
    Cosimelli B; Taliani S; Greco G; Novellino E; Sala A; Severi E; Da Settimo F; La Motta C; Pugliesi I; Antonioli L; Fornai M; Colucci R; Blandizzi C; Daniele S; Trincavelli ML; Martini C
    ChemMedChem; 2011 Oct; 6(10):1909-18. PubMed ID: 21796795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel curcumin analog (cis-trans curcumin) as ligand to adenosine receptors A
    Hamilton LJ; Walker M; Pattabiraman M; Zhong HA; Luedtke B; Chandra S
    Pharmacol Res; 2021 Mar; 165():105410. PubMed ID: 33401004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.
    Gonçalves FQ; Pires J; Pliassova A; Beleza R; Lemos C; Marques JM; Rodrigues RJ; Canas PM; Köfalvi A; Cunha RA; Rial D
    Eur J Neurosci; 2015 Apr; 41(7):878-88. PubMed ID: 25704806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors.
    Macchia M; Salvetti F; Bertini S; Di Bussolo V; Gattuso L; Gesi M; Hamdan M; Klotz KN; Laragione T; Lucacchini A; Minutolo F; Nencetti S; Papi C; Tuscano D; Martini C
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3023-6. PubMed ID: 11714602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as potent and selective A₂B adenosine receptor antagonists.
    Baraldi PG; Baraldi S; Saponaro G; Preti D; Romagnoli R; Piccagli L; Cavalli A; Recanatini M; Moorman AR; Zaid AN; Varani K; Borea PA; Tabrizi MA
    J Med Chem; 2012 Jan; 55(2):797-811. PubMed ID: 22148859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivatives.
    Taliani S; Trincavelli ML; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Daniele S; Giacomelli C; Greco G; Novellino E; Martini C; Da Settimo F
    Eur J Med Chem; 2013 Nov; 69():331-7. PubMed ID: 24077183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of A1 and A2b adenosine receptors on adipogenesis.
    Gharibi B; Abraham AA; Ham J; Evans BA
    Int J Obes (Lond); 2012 Mar; 36(3):397-406. PubMed ID: 21730968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel positive allosteric modulators of A
    Barresi E; Giacomelli C; Marchetti L; Baglini E; Salerno S; Greco G; Da Settimo F; Martini C; Trincavelli ML; Taliani S
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):286-294. PubMed ID: 33334192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.